| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.500 | None | 0.983 | 114 | 6 | 1991 | 2020 | ||||||||
|
CD34 molecule | 0.368 | 0.808 | 5.0E-06 |
|
group | 0.100 | None | 0.991 | 114 | 0 | 1994 | 2020 | ||||||||
|
RUNX family transcription factor 1 | 0.425 | 0.808 | 0.65 |
|
group | 0.500 | None | 1.000 | 88 | 0 | 1993 | 2020 | ||||||||
|
tet methylcytosine dioxygenase 2 | 0.458 | 0.808 | 4.3E-54 |
|
group | 0.800 | limited | 0.973 | 73 | 2 | 2009 | 2020 | ||||||||
|
splicing factor 3b subunit 1 | 0.511 | 0.731 | 1.00 |
|
group | 0.800 | limited | 0.971 | 70 | 1 | 2011 | 2020 | ||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
group | 0.500 | strong | 0.963 | 53 | 0 | 1984 | 2020 | ||||||||
|
ASXL transcriptional regulator 1 | 0.482 | 0.808 | 1.3E-14 |
|
group | 0.800 | None | 0.960 | 48 | 1 | 2009 | 2019 | ||||||||
|
erythropoietin | 0.381 | 0.885 | 1.1E-02 |
|
group | 0.400 | None | 0.935 | 44 | 1 | 1990 | 2020 | ||||||||
|
colony stimulating factor 3 | 0.377 | 0.885 | 0.38 |
|
group | 0.100 | None | 0.977 | 42 | 0 | 1990 | 2020 | ||||||||
|
fms related receptor tyrosine kinase 3 | 0.462 | 0.654 | 0.61 |
|
group | 0.100 | None | 0.977 | 41 | 1 | 1997 | 2019 | ||||||||
|
nucleoporin 98 and 96 precursor | 0.532 | 0.577 | 1.00 |
|
group | 0.100 | None | 1.000 | 37 | 0 | 1999 | 2019 | ||||||||
|
GATA binding protein 2 | 0.496 | 0.654 | 0.98 |
|
group | 0.800 | None | 0.976 | 37 | 1 | 2002 | 2019 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
group | 0.100 | None | 0.914 | 35 | 0 | 1996 | 2018 | ||||||||
|
MDS1 and EVI1 complex locus | 0.513 | 0.731 | 1.00 |
|
group | 0.400 | None | 1.000 | 33 | 1 | 1994 | 2018 | ||||||||
|
cyclin dependent kinase inhibitor 2B | 0.417 | 0.769 | 7.3E-03 |
|
group | 0.400 | None | 0.970 | 32 | 0 | 1995 | 2019 | ||||||||
|
Janus kinase 2 | 0.385 | 0.885 | 0.65 |
|
group | 0.200 | None | 0.969 | 30 | 1 | 2005 | 2020 | ||||||||
|
serine and arginine rich splicing factor 2 | 0.561 | 0.731 | 0.48 |
|
group | 0.500 | None | 1.000 | 30 | 1 | 2012 | 2020 | ||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
group | 0.200 | None | 1.000 | 29 | 0 | 1987 | 2019 | ||||||||
|
nucleophosmin 1 | 0.464 | 0.846 | 1.00 |
|
group | 0.100 | None | 0.966 | 29 | 0 | 1996 | 2019 | ||||||||
|
lysine methyltransferase 2A | 0.410 | 0.885 | 1.00 |
|
group | 0.100 | None | 0.931 | 28 | 0 | 1997 | 2019 | ||||||||
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
group | 0.400 | None | 0.962 | 26 | 0 | 2010 | 2019 | ||||||||
|
U2 small nuclear RNA auxiliary factor 1 | 0.604 | 0.577 | 0.99 |
|
group | 0.800 | None | 0.963 | 26 | 2 | 2011 | 2020 | ||||||||
|
C-C motif chemokine receptor 7 | 0.443 | 0.769 | 5.8E-02 |
|
group | 0.100 | None | 1.000 | 26 | 0 | 1994 | 2018 | ||||||||
|
isocitrate dehydrogenase (NADP(+)) 1 | 0.424 | 0.808 | 2.6E-12 |
|
group | 0.200 | None | 1.000 | 25 | 3 | 2010 | 2019 | ||||||||
|
colony stimulating factor 2 | 0.330 | 0.962 | 0.83 |
|
group | 0.100 | None | 1.000 | 22 | 0 | 1989 | 2018 |